<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00586040</url>
  </required_header>
  <id_info>
    <org_study_id>2006p001528</org_study_id>
    <nct_id>NCT00586040</nct_id>
  </id_info>
  <brief_title>Photochemical Tissue Bonding</brief_title>
  <acronym>PTB</acronym>
  <official_title>Photochemical Tissue Bonding (PTB) for Excisional Wound Healing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The broad aim of this study is to evaluate the efficacy of photochemical tissue bonding (PTB)&#xD;
      for the closure of skin excisions. We will test the hypothesis that full thickness skin&#xD;
      excisions treated with PTB can heal with less scarring than those treated with the&#xD;
      conventional suture closure method.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypertrophic scarring is a frequent endpoint after traditional surgical excision of skin&#xD;
      cancers of the chest. These scars create significant long-term morbidity to the patient.&#xD;
      There is a clinical need for an alternative treatment that would reduce factors associated&#xD;
      with hypertrophic and possibly keloid scar formation by providing minimal tension, low&#xD;
      infection risk and an absence of foreign body material. This would result in a normal&#xD;
      appearing and healed scar without associated patient morbidity. Photochemical tissue bonding&#xD;
      may provide this alternate treatment. PTB differs from sutures by continuously joining the&#xD;
      tissue surfaces on a molecular level rather than only at discrete suture points. In addition,&#xD;
      PTB does not incite foreign body reactions nor create tissue injury during passage of the&#xD;
      needle and tying a knot, injuries that may initiate scarring.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>scar appearance</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Basal Cell Carcinoma</condition>
  <condition>Squamous Cell Carcinoma</condition>
  <condition>Atypical Nevus</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>superficial closure with PTB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>superficial sutures</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tissue bonding</intervention_name>
    <description>application of rose bengal and treatment with green light</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sutures</intervention_name>
    <description>interrupted superficial sutures</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Histopathology confirmed basal cell carcinoma or well-differentiated squamous cell&#xD;
             carcinoma without subcutaneous fat invasion on the chest, arm or abdomen or a&#xD;
             diagnosis of atypical or dysplastic nevi on the chest, arm or abdomen.&#xD;
&#xD;
          -  Able to follow involved post-operative care instructions&#xD;
&#xD;
          -  Able to comply with study requirements&#xD;
&#xD;
          -  Age 20-60 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        History of underlying photosensitivity condition Skin phototypes V-VI Use of&#xD;
        photosensitizing medication History of Accutane use within the past 12 months History of&#xD;
        underlying bleeding disorder or use of anticoagulant (e.g. coumadin) Active smoker Known&#xD;
        pregnancy or lactating mother Allergies or reactions to lidocaine or epinephrine Underlying&#xD;
        immunodeficiency Inability to comply with study requirements Pacemaker or defibrillator in&#xD;
        place&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irene E Kochevar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.massgeneral.org/wellman/</url>
    <description>Wellman Center for Photomedicine</description>
  </link>
  <link>
    <url>http://www.mgh.harvard.edu/mghdermatology/</url>
    <description>Department of Dermatology, Massachusetts General Hospital</description>
  </link>
  <verification_date>April 2009</verification_date>
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2008</study_first_posted>
  <last_update_submitted>April 9, 2009</last_update_submitted>
  <last_update_submitted_qc>April 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>Irene E. Kochevar</name_title>
    <organization>Massachusetts General Hospital</organization>
  </responsible_party>
  <keyword>skin cancer</keyword>
  <keyword>skin excision</keyword>
  <keyword>laser</keyword>
  <keyword>superficial sutures</keyword>
  <keyword>wound healing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

